We are live on ! Find out more
MCP

Mirador Capital Partners Portfolio holdings

AUM $817M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+42.46%
3 Year Est. Return
+102.43%
5 Year Est. Return
+126.93%
10 Year Est. Return
+392.96%
AUM
$422M
AUM Growth
-$181K
Cap. Flow
-$11.2M
Cap. Flow %
-2.65%
Top 10 Hldgs %
38.95%
Holding
202
New
14
Increased
60
Reduced
106
Closed
13

Top Buys

Rank Stock Value
1
BSJO
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
+$20.1M
2
NDAQ icon
Nasdaq
NDAQ
+$3.36M
3
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$2.75M
4
PFE icon
Pfizer
PFE
+$2.61M
5
MMM icon
3M
MMM
+$2.52M

Top Sells

Rank Stock Value
1
SH icon
ProShares Short S&P500
SH
+$12.6M
2
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
+$8.93M
3
BSJN
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
+$8.72M
4
BSCO
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
+$4.51M
5
PSQ icon
ProShares Short QQQ
PSQ
+$3.2M

Sector Composition

Rank Sector Weight
1 Financials 15.24%
2 Technology 15.2%
3 Healthcare 13.3%
4 Communication Services 8.02%
5 Consumer Discretionary 6.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARE icon
176
Alexandria Real Estate Equities
ARE
$8.32B
$220K 0.05%
1,936
-144
-7% -$17.1K
GTLB icon
177
GitLab
GTLB
$6.88B
$215K 0.05%
+4,209
New +$156K
XOP icon
178
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.62B
$212K 0.05%
+1,647
New +$206K
VGR
179
DELISTED
Vector Group Ltd.
VGR
$205K 0.05%
16,027
-640
-4% -$7.89K
PACB icon
180
Pacific Biosciences
PACB
$357M
$153K 0.04%
11,475
-1,500
-12% -$18.2K
BTZ icon
181
BlackRock Credit Allocation Income Trust
BTZ
$958M
$150K 0.04%
14,824
-10,989
-43% -$113K
HLN icon
182
Haleon
HLN
$43.7B
$130K 0.03%
15,490
-88
-0.6% -$751
VCV icon
183
Invesco California Value Municipal Income Trust
VCV
$525M
$113K 0.03%
11,773
-9,573
-45% -$92.8K
LAB icon
184
Standard BioTools
LAB
$310M
$92.6K 0.02%
+47,956
New +$94.7K
COYA icon
185
Coya Therapeutics
COYA
$109M
$62.5K 0.01%
+15,361
New +$71.3K
BCLI
186
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$51.7K 0.01%
+1,672
New +$69.3K
PLBY icon
187
Playboy Inc
PLBY
$136M
$49.9K 0.01%
29,690
+5,500
+23% +$9.29K
ASXC
188
DELISTED
Asensus Surgical, Inc.
ASXC
$30.3K 0.01%
60,039
– –
PCSA icon
189
Processa Pharmaceuticals
PCSA
$8.75M
$9.33K ﹤0.01%
38
-3
-7% -$886
CSIQ icon
190
Canadian Solar
CSIQ
$1.06B
– –
-5,270
Closed -$210K
DUK icon
191
Duke Energy
DUK
$94.5B
– –
-2,343
Closed -$226K
GLO
192
Clough Global Opportunities Fund
GLO
$257M
– –
-37,579
Closed -$184K
PCAR icon
193
PACCAR
PCAR
$69.1B
– –
-3,000
Closed -$220K
PD icon
194
PagerDuty
PD
$916M
– –
-11,845
Closed -$414K
S icon
195
SentinelOne
S
$7.62B
– –
-16,357
Closed -$268K
T icon
196
AT&T
T
$165B
– –
-33,695
Closed -$649K
TOST icon
197
Toast
TOST
$20.6B
– –
-14,657
Closed -$260K
UPS icon
198
United Parcel Service
UPS
$89.1B
– –
-1,088
Closed -$211K
CUTR
199
DELISTED
Cutera, Inc.
CUTR
– –
-10,843
Closed -$256K
AYX
200
DELISTED
Alteryx Inc
AYX
– –
-7,100
Closed -$418K
5 6 7
8
9

Similar funds

BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
ACM
Arvin Capital Management Austin, Texas $819M AUM 24.75% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
DI
DUMAC Inc Durham, North Carolina $820M AUM
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
VT
Volterra Technologies New York $823M AUM 28.93% 1-Year Est. Return

Mirador Capital Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Mirador Capital Partners held 202 positions worth $422M, down 0.04% from $422M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Mirador Capital Partners's Q2 2023 filing shows 14 new, 60 increased, 106 reduced and 13 closed positions. Its largest new stake was Nasdaq: 62,091 shares worth $3.1M. The largest sale was ProShares Short S&P500, an estimated $12.6M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Mirador Capital Partners's largest Q2 2023 buy was Nasdaq: 62,091 shares worth $3.1M.
  • Mirador Capital Partners added most to Invesco BulletShares 2024 High Yield Corporate Bond ETF in Q2 2023, an estimated $20.1M increase.
  • Mirador Capital Partners's biggest Q2 2023 reduction was ProShares Short S&P500, cutting an estimated $12.6M.
  • Mirador Capital Partners fully exited AT&T in Q2 2023, selling an estimated $649K.
  • Mirador Capital Partners's ten largest holdings make up 39% of its $422M portfolio in Q2 2023.
  • Mirador Capital Partners opened 14 new positions and closed 13 in Q2 2023.
  • Mirador Capital Partners's portfolio value fell 0.04% quarter-over-quarter to $422M.

Based on Mirador Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.